Trials / Completed
CompletedNCT02769273
Stellarex Vascular E-Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,900 (actual)
- Sponsor
- Spectranetics Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, international, multi-center, single arm, observational study to continue to assess the treatment by the Stellarex™ OTW Drug-coated Angioplasty Balloon in superficial femoral and/or popliteal arteries according to the Instructions for Use in a broad, real-world, claudicant or ischemic rest pain patients population per the institution's standard practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous Transluminal Angioplasty |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2021-10-31
- Completion
- 2021-12-01
- First posted
- 2016-05-11
- Last updated
- 2025-08-14
Locations
46 sites across 6 countries: Austria, Belgium, France, Germany, Italy, United Kingdom
Source: ClinicalTrials.gov record NCT02769273. Inclusion in this directory is not an endorsement.